arrow
I

Irene L. Andrulis

University of Toronto
H指数:107
被引数:4.8万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clarifying risk-factor associations with quantitative breast tumor features: a pooled analysis of 24 studies

阐明风险因素与定量乳腺肿瘤特征的关系:24项研究的合并分析

2026-07-240
PRE
Steroids, stress, and body mass index interact to accelerate female pubertal development

类固醇、压力和体重指数相互作用以加速女性青春期发育

2026-04-070
PRE
Genome-wide association study of 398,238 women unveils seven loci associated with high-grade serous ovarian cancer

398,238名女性的全基因组关联研究揭示了七个与高级别浆液性卵巢癌相关的位点

2025-11-200
OAAI
Threshold-Based Overlap of Breast Cancer High-Risk Classification Using Family History, Polygenic Risk Scores, and Traditional Risk Models in 180,398 Women

基于家族史、多基因风险评分和传统风险模型的乳腺癌高风险分类阈值重叠:一项针对180,398名女性的研究

2025-11-030
OAAI
The Terry Fox Research Institute Marathon of Hope Cancer Centres Network: A pan-Canadian precision oncology initiative

Terry Fox Research Institute马拉松希望癌症中心网络:一项全加拿大的精准肿瘤学倡议

2025-04-010
PRE
Polygenic score distribution differences across European ancestry populations: implications for breast cancer risk prediction

欧洲血统人群的多基因得分分布差异: 对乳腺癌风险预测的影响

2024-12-290
OAAI
Physical Activity during Adolescence and Early Adulthood and Breast Cancer Risk before Age 40 Years

青春期和成年早期的身体活动与40岁之前的乳腺癌风险

2024-10-150
OA
A transcriptional atlas provides a universal diagnostic platform for mesenchymal tumors and validation of preclinical models
2024-09-050
PRE
Co-observation of germline pathogenic variants in breast cancer predisposition genes: Results from analysis of the BRIDGES sequencing dataset

乳腺癌易感基因种系致病变异的共同观察: BRIDGES测序数据集的分析结果

2024-09-013
PRE
Understanding the genetic complexity of puberty timing across the allele frequency spectrum

了解等位基因频谱中青春期时间的遗传复杂性

2024-07-013
OAAI
Hormonal Contraception and Breast Cancer Risk for Carriers of Germline Pathogenic Variants in BRCA1 and BRCA2
2024-05-020
PRE
Disentangling the relationships of body mass index and circulating sex hormone concentrations in mammographic density using Mendelian randomization

使用孟德尔随机化解开乳房x线密度中体重指数和循环性激素浓度的关系

2024-04-242
PRE
Underlying germline genetic architecture of pediatric sarcomas: Evaluating the role of common and rare variants in 4,160 patients
2024-03-220
PRE
Polymorphisms in genes of melatonin biosynthesis and signaling support the light-at-night hypothesis for breast cancer

褪黑激素生物合成和信号传导基因的多态性支持乳腺癌夜间光照假说

2023-10-033
OAAI
A Likelihood Ratio Approach for Utilizing Case-Control Data in the Clinical Classification of Rare Sequence Variants: Application to BRCA1 and BRCA2

在罕见序列变异的临床分类中利用病例对照数据的似然比方法: 在BRCA1和BRCA2中的应用

2023-09-141
OAAI
Evaluation of European-based polygenic risk score for breast cancer in Ashkenazi Jewish women in Israel

基于欧洲的以色列Ashkenazi犹太妇女乳腺癌多基因风险评分评估

2023-07-141
OAAI
PREDICT validity for prognosis of breast cancer patients with pathogenic BRCA1/2 variants

致病性BRCA1/2变异对乳腺癌患者预后的预测效度

2023-05-123
OAAI
Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

卵巢癌病理特征是BRCA1和BRCA2变异致病性的预测因子

2023-04-198
OA
Functional genomics of human clear cell sarcoma: genomic, transcriptomic and chemical biology landscape for clear cell sarcoma
2023-03-230
OA